RHYTHM AI cleared for large trial of atrial fibrillation map...

UK-based RHYTHM AI is to go ahead with a larger clinical trial of its artificial intelligence (AI)-driven system, which could be used as a treatment for atrial fibrillation without the need

AI study will help select AFib patients for shock treatment

AI-driven atrial fibrillation project begins after seed fund...

Clinical development of an AI-driven system that identifies the sources or drivers of atrial fibrillation (AF), and could prevent the need for medication, has got off the ground after the p

Lixiana hits the mark in catheter ablation trial

Daiichi Sankyo’s Lixiana was a late entrant to the novel oral anticoagulant (NOAC) category, but the Japanese drugmaker hopes new data in atrial fibrillation (AFib) could accelerate its gro

Apple Watch shows early promise in AFib diagnosis

A large-scale study has provided some evidence that the Apple Watch could be used to detect atrial fibrillation (AFib) and provide a potentially life-saving early warning for the condition

J&J partners with Apple for ECG monitoring project

Apple has a new big pharma partner to help put its new Apple Watch with built-in electrocardiogram (ECG) through its paces, signing an alliance with Johnson & Johnson.